Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction
Clinical and Experimental Immunology · 16.05.2024 · 216 (3) · 262-271
DOI: 10.1093/cei/uxae014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 22.02.2024. Verfasst von Elena Berenice Martínez-Shio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San L…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Myocardial Infarction, Interleukin-10, Antigens, CD. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Proyecto de Conacyt Ciencia Básica.
Abstract (Originalsprache)
A high percentage of patients with acute coronary syndrome develop heart failure due to the ischemic event. Regulatory T (Treg) cells are lymphocytes with suppressive capacity that control the immune response and include the conventional CD4+ CD25hi Foxp3+ cells and the CD4+ CD25var CD69+ LAP+ Foxp3− IL-10+ cells. No human follow-up studies focus on Treg cells’ behavior after infarction and their possible relationship with ventricular function as a sign of postischemic cardiac remodeling. This study aimed to analyze, by flow cytometry, the circulating levels of CD69+ Treg cells and CD4+ CD25hi Foxp3+ cells, their IL-10+ production as well as their function in patients with acute myocardial infarction (AMI), and its possible relation with ventricular dysfunction. We found a significant difference in the percentage of CD4+ CD25hi Foxp3+ cells and IL-10+ MFI in patients with AMI at 72 hours compared with the healthy control group, and the levels of these cells were reduced 6 months post-AMI. Regarding the suppressive function of CD4+ CD25+ regulatory cells, they were dysfunctional at 3 and 6 months post-AMI. The frequency of CD69+ Treg cells was similar between patients with AMI at 72 hours postinfarction and the control groups. Moreover, the frequency of CD69+ Treg cells at 3 and 6 months postischemic event did not vary over time. Treg cells play a role in regulating inflammation after an AMI, and its function may be compromised in this pathology. This work is the first report to evaluate CD69+ Foxp3− Treg cells in AMI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
- Departamento de Cardiología, Hospital Central 'Ignacio Morones Prieto', San Luis Potosí, México.
ORCID-Profile: Elena Berenice Martínez-Shio, Roberto González-Amaro, Adriana Elizabeth Monsiváis-Urenda
Förderung
- Proyecto de Conacyt Ciencia Básica
Zitieren
APA
Martínez-Shio, E. B., Marín-Jáuregui, L. S., Rodríguez-Ortega, A. C., Doníz-Padilla, L. M., González-Amaro, R., Escobedo-Uribe, C. D., & Monsiváis-Urenda, A. E. (2024). Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction. Clinical and Experimental Immunology, 216(3), 262-271. https://doi.org/10.1093/cei/uxae014
Vancouver
Martínez-Shio EB, Marín-Jáuregui LS, Rodríguez-Ortega AC, Doníz-Padilla LM, González-Amaro R, Escobedo-Uribe CD, et al. Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction. Clinical and Experimental Immunology. 2024;216(3):262-271. doi:10.1093/cei/uxae014
BibTeX
@article{MartnezShio2024,
author = {Martínez-Shio, Elena Berenice and Marín-Jáuregui, Laura Sherell and Rodríguez-Ortega, Alma Celeste and Doníz-Padilla, Lesly Marsol and González-Amaro, Roberto and Escobedo-Uribe, Carlos David and Monsiváis-Urenda, Adriana Elizabeth},
title = {Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction},
journal = {Clinical and Experimental Immunology},
year = {2024},
volume = {216},
number = {3},
pages = {262--271},
doi = {10.1093/cei/uxae014}
}
EUVIMED